Nanosort, Inc.

San Diego, CA 92122
http://nanocellect.com/

SBIR Award Summary

Total Number of Awards 19
Total Value of Awards $6.7MM
First Award Date 09/01/10
Most Recent Award Date 09/30/17

Key Personnel

Last Name Name Awards Contact
Morachis Jose Manuel Morachis 15
Lo Yu-Hwa Lo 15
Bazhenova Lyudmila Bazhenova 2
O'Shea Clodagh O'Shea 2
Cho Sung Hwan Cho 4
GOLDSTEIN LAWRENCE S. GOLDSTEIN 4
CHEN CLARK CHIN-CHUNG CHEN 1

19 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-16-302
Budget: 09/30/17 - 08/31/18
PI: Yu-Hwa Lo

iFACS: Imaging Florescence Activated Cell Sorter to sort cells based on images NanoCellect Biomedical, Inc. RESEARCH & RELATED Other Project Information 7. PROJECT SUMMARY Advances in reagents (e.g. CRiSPR) and analytical tools (e.g. flow cytometers) have improved the ability to alter and characterize cellular phenotypes. Ultimately, many key ap...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-16-302
Budget: 09/08/17 - 08/31/18

High-throughput single-cell sorting and kinetic analysis of secreted particles NanoCellect Biomedical, Inc. RESEARCH & RELATED Other Project Information 7. PROJECT SUMMARY Advances in reagents and analytical tools have improved characterization of cellular phenotypes. However, most studies are still performed on cell populations that are morphol...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-335
Budget: 07/01/16 - 06/30/17

DESCRIPTION (provided by applicant): Fluorescence-activated-cell-sorting (FACS) or flow cytometry enables clinicians and researchers to quantitatively characterize the physical (cell size, shape, granularity) and biochemical (DNA content, cell cycle distribution, cell surface markers, and viability) properties of cells. With the capability of hi...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-15-269
Budget: 04/15/16 - 03/31/17
PI: Yu-Hwa Lo

? DESCRIPTION (provided by applicant): Fluorescence-activated-cell-sorting (FACS) or flow cytometry enables clinicians and researchers to quantitatively characterize the physical (cell size, shape, and granularity) and biochemical (DNA content, cell cycle distribution, cell surface markers, and viability) properties of cells, however FACS dev...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-13-140
Budget: 09/01/15 - 08/31/16

DESCRIPTION (provided by applicant): Advances in reagents and analytical tools have improved characterization of cellular phenotypes. However, most studies are still performed on cell populations that are morphologically and genetically homogeneous, yet have important biological heterogeneity;with individual cells having unique phenotypic or `om...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-335
Budget: 07/01/15 - 06/30/16

DESCRIPTION (provided by applicant): Fluorescence-activated-cell-sorting (FACS) or flow cytometry enables clinicians and researchers to quantitatively characterize the physical (cell size, shape, granularity) and biochemical (DNA content, cell cycle distribution, cell surface markers, and viability) properties of cells. With the capability of hi...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-12-149
Budget: 09/01/14 - 06/30/15

DESCRIPTION (provided by applicant): Fluorescence-activated-cell-sorting (FACS) or flow cytometry enables clinicians and researchers to quantitatively characterize the physical (cell size, shape, granularity) and biochemical (DNA content, cell cycle distribution, cell surface markers, and viability) properties of cells. With the capability of hi...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-335
Budget: 09/01/14 - 06/30/15

DESCRIPTION (provided by applicant): Fluorescence-activated-cell-sorting (FACS) or flow cytometry enables clinicians and researchers to quantitatively characterize the physical (cell size, shape, granularity) and biochemical (DNA content, cell cycle distribution, cell surface markers, and viability) properties of cells. With the capability of hi...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-335
Budget: 09/01/14 - 08/31/15

DESCRIPTION (provided by applicant): This proposal describes a novel method for rapidly counting neutrophils in a patient's blood sample. Neutropenia, characterized by an abnormally low number of neutrophils that serve as the primary defense against infections, is a common side effect of chemotherapy. Without prompt medical attention, the condit...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-335
Budget: 09/20/13 - 08/31/14

DESCRIPTION (provided by applicant): This proposal describes a novel method for rapidly counting neutrophils in a patient's blood sample. Neutropenia, characterized by an abnormally low number of neutrophils that serve as the primary defense against infections, is a common side effect of chemotherapy. Without prompt medical attention, the condit...

Load More